Introduction
Neurologic involvement is a frequent feature of human immunodeficiency virus (HIV) infection and may be the initial presentation in about 10% of patients. 2 There is increasing evidence that indirect mechanisms, such as the release of cytokines, play an important role in mediating brain inflammation in HIV infection. Indeed it is now widely acknowledged that tumour necrosis factor-(TNF-z), a central mediator of inflammation, plays a crucial role in the development of acquired immunodeficiency syndrome (AIDS). 3 4 Such vascular inflammation seems to be immune mediated 4 's and could be connected to the release of inflammatory mediators.
Evidence has been presented that TNF-z induces inflammatory changes on human cerebral endothelial cells. 6'7 Moreover, we have recently shown in a different series of patients that TNF-o mediates blood-brain barrier damage in HIV infected patients. 8 However, the Albumin quotient x 1000) 
